Cargando…
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
AIMS: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract. METHODS AND RESULTS: A literature search covering 2000–2017 was performed. The Panel critically...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047411/ https://www.ncbi.nlm.nih.gov/pubmed/29718253 http://dx.doi.org/10.1093/eurheartj/ehy182 |
_version_ | 1783339940508073984 |
---|---|
author | Mach, François Ray, Kausik K Wiklund, Olov Corsini, Alberto Catapano, Alberico L Bruckert, Eric De Backer, Guy Hegele, Robert A Hovingh, G Kees Jacobson, Terry A Krauss, Ronald M Laufs, Ulrich Leiter, Lawrence A März, Winfried Nordestgaard, Børge G Raal, Frederick J Roden, Michael Santos, Raul D Stein, Evan A Stroes, Erik S Thompson, Paul D Tokgözoğlu, Lale Vladutiu, Georgirene D Gencer, Baris Stock, Jane K Ginsberg, Henry N Chapman, M John |
author_facet | Mach, François Ray, Kausik K Wiklund, Olov Corsini, Alberto Catapano, Alberico L Bruckert, Eric De Backer, Guy Hegele, Robert A Hovingh, G Kees Jacobson, Terry A Krauss, Ronald M Laufs, Ulrich Leiter, Lawrence A März, Winfried Nordestgaard, Børge G Raal, Frederick J Roden, Michael Santos, Raul D Stein, Evan A Stroes, Erik S Thompson, Paul D Tokgözoğlu, Lale Vladutiu, Georgirene D Gencer, Baris Stock, Jane K Ginsberg, Henry N Chapman, M John |
author_sort | Mach, François |
collection | PubMed |
description | AIMS: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract. METHODS AND RESULTS: A literature search covering 2000–2017 was performed. The Panel critically appraised the data and agreed by consensus on the categorization of reported adverse effects. Randomized controlled trials (RCTs) and genetic studies show that statin therapy is associated with a modest increase in the risk of new-onset diabetes mellitus (about one per thousand patient-years), generally defined by laboratory findings (glycated haemoglobin ≥6.5); this risk is significantly higher in the metabolic syndrome or prediabetes. Statin treatment does not adversely affect cognitive function, even at very low levels of low-density lipoprotein cholesterol and is not associated with clinically significant deterioration of renal function, or development of cataract. Transient increases in liver enzymes occur in 0.5–2% of patients taking statins but are not clinically relevant; idiosyncratic liver injury due to statins is very rare and causality difficult to prove. The evidence base does not support an increased risk of haemorrhagic stroke in individuals without cerebrovascular disease; a small increase in risk was suggested by the Stroke Prevention by Aggressive Reduction of Cholesterol Levels study in subjects with prior stroke but has not been confirmed in the substantive evidence base of RCTs, cohort studies and case–control studies. CONCLUSION: Long-term statin treatment is remarkably safe with a low risk of clinically relevant adverse effects as defined above; statin-associated muscle symptoms were discussed in a previous Consensus Statement. Importantly, the established cardiovascular benefits of statin therapy far outweigh the risk of adverse effects. |
format | Online Article Text |
id | pubmed-6047411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60474112018-07-19 Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract Mach, François Ray, Kausik K Wiklund, Olov Corsini, Alberto Catapano, Alberico L Bruckert, Eric De Backer, Guy Hegele, Robert A Hovingh, G Kees Jacobson, Terry A Krauss, Ronald M Laufs, Ulrich Leiter, Lawrence A März, Winfried Nordestgaard, Børge G Raal, Frederick J Roden, Michael Santos, Raul D Stein, Evan A Stroes, Erik S Thompson, Paul D Tokgözoğlu, Lale Vladutiu, Georgirene D Gencer, Baris Stock, Jane K Ginsberg, Henry N Chapman, M John Eur Heart J Clinical Review AIMS: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract. METHODS AND RESULTS: A literature search covering 2000–2017 was performed. The Panel critically appraised the data and agreed by consensus on the categorization of reported adverse effects. Randomized controlled trials (RCTs) and genetic studies show that statin therapy is associated with a modest increase in the risk of new-onset diabetes mellitus (about one per thousand patient-years), generally defined by laboratory findings (glycated haemoglobin ≥6.5); this risk is significantly higher in the metabolic syndrome or prediabetes. Statin treatment does not adversely affect cognitive function, even at very low levels of low-density lipoprotein cholesterol and is not associated with clinically significant deterioration of renal function, or development of cataract. Transient increases in liver enzymes occur in 0.5–2% of patients taking statins but are not clinically relevant; idiosyncratic liver injury due to statins is very rare and causality difficult to prove. The evidence base does not support an increased risk of haemorrhagic stroke in individuals without cerebrovascular disease; a small increase in risk was suggested by the Stroke Prevention by Aggressive Reduction of Cholesterol Levels study in subjects with prior stroke but has not been confirmed in the substantive evidence base of RCTs, cohort studies and case–control studies. CONCLUSION: Long-term statin treatment is remarkably safe with a low risk of clinically relevant adverse effects as defined above; statin-associated muscle symptoms were discussed in a previous Consensus Statement. Importantly, the established cardiovascular benefits of statin therapy far outweigh the risk of adverse effects. Oxford University Press 2018-07-14 2018-04-27 /pmc/articles/PMC6047411/ /pubmed/29718253 http://dx.doi.org/10.1093/eurheartj/ehy182 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Review Mach, François Ray, Kausik K Wiklund, Olov Corsini, Alberto Catapano, Alberico L Bruckert, Eric De Backer, Guy Hegele, Robert A Hovingh, G Kees Jacobson, Terry A Krauss, Ronald M Laufs, Ulrich Leiter, Lawrence A März, Winfried Nordestgaard, Børge G Raal, Frederick J Roden, Michael Santos, Raul D Stein, Evan A Stroes, Erik S Thompson, Paul D Tokgözoğlu, Lale Vladutiu, Georgirene D Gencer, Baris Stock, Jane K Ginsberg, Henry N Chapman, M John Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
title | Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
title_full | Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
title_fullStr | Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
title_full_unstemmed | Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
title_short | Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
title_sort | adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
topic | Clinical Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047411/ https://www.ncbi.nlm.nih.gov/pubmed/29718253 http://dx.doi.org/10.1093/eurheartj/ehy182 |
work_keys_str_mv | AT machfrancois adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT raykausikk adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT wiklundolov adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT corsinialberto adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT catapanoalbericol adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT bruckerteric adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT debackerguy adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT hegeleroberta adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT hovinghgkees adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT jacobsonterrya adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT kraussronaldm adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT laufsulrich adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT leiterlawrencea adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT marzwinfried adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT nordestgaardbørgeg adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT raalfrederickj adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT rodenmichael adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT santosrauld adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT steinevana adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT stroeseriks adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT thompsonpauld adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT tokgozoglulale adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT vladutiugeorgirened adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT gencerbaris adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT stockjanek adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT ginsberghenryn adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT chapmanmjohn adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract AT adverseeffectsofstatintherapyperceptionvstheevidencefocusonglucosehomeostasiscognitiverenalandhepaticfunctionhaemorrhagicstrokeandcataract |